Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The ARRONAX project.
Haddad F, Barbet J, Chatal JF. Haddad F, et al. Among authors: chatal jf. Curr Radiopharm. 2011 Jul;4(3):186-96. doi: 10.2174/1874471011104030186. Curr Radiopharm. 2011. PMID: 22201708 Review.
ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine.
Haddad F, Ferrer L, Guertin A, Carlier T, Michel N, Barbet J, Chatal JF. Haddad F, et al. Among authors: chatal jf. Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1377-87. doi: 10.1007/s00259-008-0802-5. Epub 2008 May 9. Eur J Nucl Med Mol Imaging. 2008. PMID: 18465127
What can be expected from nuclear medicine tomorrow?
Barbet J, Kraeber-Bodéré F, Chatal JF. Barbet J, et al. Among authors: chatal jf. Cancer Biother Radiopharm. 2008 Aug;23(4):483-504. doi: 10.1089/cbr.2008.010-U. Cancer Biother Radiopharm. 2008. PMID: 18771353 Review.
Tumor immunotargeting using innovative radionuclides.
Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Mathieu C, Guérard F, Frampas E, Carlier T, Chouin N, Haddad F, Chatal JF, Faivre-Chauvet A, Chérel M, Barbet J. Kraeber-Bodéré F, et al. Among authors: chatal jf. Int J Mol Sci. 2015 Feb 11;16(2):3932-54. doi: 10.3390/ijms16023932. Int J Mol Sci. 2015. PMID: 25679452 Free PMC article. Review.
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
Kraeber-Bodéré F, Rousseau C, Bodet-Milin C, Ferrer L, Faivre-Chauvet A, Campion L, Vuillez JP, Devillers A, Chang CH, Goldenberg DM, Chatal JF, Barbet J. Kraeber-Bodéré F, et al. Among authors: chatal jf. J Nucl Med. 2006 Feb;47(2):247-55. J Nucl Med. 2006. PMID: 16455630 Free article. Clinical Trial.
Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.
Oudoux A, Salaun PY, Bournaud C, Campion L, Ansquer C, Rousseau C, Bardet S, Borson-Chazot F, Vuillez JP, Murat A, Mirallié E, Barbet J, Goldenberg DM, Chatal JF, Kraeber-Bodéré F. Oudoux A, et al. Among authors: chatal jf. J Clin Endocrinol Metab. 2007 Dec;92(12):4590-7. doi: 10.1210/jc.2007-0938. Epub 2007 Sep 18. J Clin Endocrinol Metab. 2007. PMID: 17878252 Clinical Trial.
[Radiolabeled antibodies for cancer treatment].
Barbet J, Chatal JF, Kraeber-Bodéré F. Barbet J, et al. Among authors: chatal jf. Med Sci (Paris). 2009 Dec;25(12):1039-45. doi: 10.1051/medsci/200925121039. Med Sci (Paris). 2009. PMID: 20035676 Free article. Review. French.
206 results